Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-08-28 | REGENERON PHARMACEUTICALS, INC. | Fenimore Christop...
(SVP Finance & CFO) |
S | Common Stock | D | 5680 | $1204.71 - $1206.70 | $6,846,260 |
| 2024-06-24 | REGENERON PHARMACEUTICALS, INC. | Bassler Bonnie L
(Director) |
S | Common Stock | D | 756 | $1062.00 - $1062.00 | $802,872 |
| 2024-06-24 | REGENERON PHARMACEUTICALS, INC. | Bassler Bonnie L
(Director) |
M | Common Stock | A | 756 | $371.40 - $371.40 | $280,778 |
| 2024-06-03 | REGENERON PHARMACEUTICALS, INC. | McCourt Marion
(EVP Commercial) |
S | Common Stock | D | 1138 | $980.16 - $980.16 | $1,115,422 |
| 2024-06-03 | REGENERON PHARMACEUTICALS, INC. | McCourt Marion
(EVP Commercial) |
M | Common Stock | A | 1138 | $372.46 - $372.46 | $423,859 |
| 2024-06-03 | REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F
(Director) |
S | Common Stock | D | 100 | $979.40 - $1000.04 | $99,442 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |